Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion type Assertion NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_head.
- NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_provenance.
- NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion evidence source_evidence_literature NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_provenance.
- NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion SIO_000772 19318581 NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_provenance.
- NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion wasDerivedFrom befree-20140225 NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_provenance.
- NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion wasGeneratedBy ECO_0000203 NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_provenance.